日本的晚期或转移性胆道癌症:使用日本医疗数据中心付款人索赔数据库的研究
Ramzi Argoubi1, Emily S Reese2, Martina Furegato1
1Cerner Enviza, Kansas City, MO 64117, USA.
Journal of comparative effectiveness research
|May 31, 2023
概括
日本的转移性胆道癌症影响了年轻人群,其特点是显著的并发病和高的医疗利用率. 治疗通常涉及吉姆西塔加西斯,并有大量的住院治疗.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 胆道癌 (BTC) 是一种具有普遍不良预后的侵袭性恶性瘤.
- 了解转移性BTC的临床环境对于改善患者的治疗结果至关重要.
研究的目的:
- 描述日本转移性胆道癌症患者的临床特征,治疗模式和医疗资源利用情况.
- 确定影响疾病负担的关键人口和并发症因素.
主要方法:
- 一项基于队列的研究利用了日本医学数据中心的索赔数据库,从2014年到2018年.
- 包括325名被诊断患有转移性胆道癌症的患者.
主要成果:
- 研究人口 (N=325) 的平均年龄为59.2岁,其中65.2%的男性和47.6%的男性具有高并发症指数 (≥5).
- 第一线化疗主要使用凝胺加西斯普拉丁 (52.9%). 第二线和第三线疗法经常涉及泰加富尔/吉梅拉西尔/奥特拉西尔.
- 观察到严重的医疗负担,大约77%的患者住院治疗,平均57天.
结论:
- 日本的转移性胆道癌症带来了相当大的疾病负担,影响了相对较年轻的患者人口统计.
- 研究结果强调,需要优化治疗策略和支持性护理,以管理与这种侵袭性癌症相关的高资源利用率.
更多相关视频
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
150
04:50Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
Published on: January 17, 2025
348
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Survival Analysis
402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
